Cardiac manifestations of the antiphospholipid syndrome.
Asherson
R A
RA
Lupus Research Unit, Rayne Institute, St. Thomas' Hospital, London, UK.
Cervera
R
R
D017153:Antibodies, Anticardiolipin / Q000097:blood; D000925:Anticoagulants / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000097:blood / Q000150:complications* / Q000628:therapy; D001241:Aspirin / Q000627:therapeutic use; D003327:Coronary Disease / Q000097:blood / Q000209:etiology* / Q000628:therapy; D006349:Heart Valve Diseases / Q000097:blood / Q000209:etiology* / Q000628:therapy; D006801:Humans; D006976:Hypertension, Pulmonary / Q000097:blood / Q000209:etiology* / Q000628:therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D012307:Risk Factors
D017153:Antibodies, Anticardiolipin; D000925:Anticoagulants; D007166:Immunosuppressive Agents; D001241:Aspirin